1. Home
  2. SQNS vs CTMX Comparison

SQNS vs CTMX Comparison

Compare SQNS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • CTMX
  • Stock Information
  • Founded
  • SQNS 2003
  • CTMX 2008
  • Country
  • SQNS France
  • CTMX United States
  • Employees
  • SQNS N/A
  • CTMX N/A
  • Industry
  • SQNS Semiconductors
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • CTMX Health Care
  • Exchange
  • SQNS Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • SQNS 85.7M
  • CTMX 85.3M
  • IPO Year
  • SQNS 2011
  • CTMX 2015
  • Fundamental
  • Price
  • SQNS $3.11
  • CTMX $0.84
  • Analyst Decision
  • SQNS Strong Buy
  • CTMX Buy
  • Analyst Count
  • SQNS 1
  • CTMX 6
  • Target Price
  • SQNS $7.50
  • CTMX $5.77
  • AVG Volume (30 Days)
  • SQNS 107.6K
  • CTMX 847.0K
  • Earning Date
  • SQNS 02-11-2025
  • CTMX 03-10-2025
  • Dividend Yield
  • SQNS N/A
  • CTMX N/A
  • EPS Growth
  • SQNS N/A
  • CTMX N/A
  • EPS
  • SQNS 1.65
  • CTMX 0.16
  • Revenue
  • SQNS $30,555,000.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • SQNS $10.14
  • CTMX $22.55
  • Revenue Next Year
  • SQNS $8.54
  • CTMX N/A
  • P/E Ratio
  • SQNS $1.90
  • CTMX $5.20
  • Revenue Growth
  • SQNS N/A
  • CTMX 33.66
  • 52 Week Low
  • SQNS $0.85
  • CTMX $0.79
  • 52 Week High
  • SQNS $7.43
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 50.30
  • CTMX 45.15
  • Support Level
  • SQNS $3.00
  • CTMX $0.82
  • Resistance Level
  • SQNS $3.64
  • CTMX $0.98
  • Average True Range (ATR)
  • SQNS 0.22
  • CTMX 0.06
  • MACD
  • SQNS -0.01
  • CTMX 0.01
  • Stochastic Oscillator
  • SQNS 34.78
  • CTMX 33.58

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: